Furthermore, chronic administration of 7,8-DHF prevented Aβ deposition, restored synaptic plasticity, and prevented memory deficits in AD transgenic mice (Zhang et al., 2014), suggesting that BDNF/TrkB signaling may have therapeutic potential in treatment of AD. This evidence concerns the gene NTRK2 and Alzheimer disease.